Crossmark

Effects of Apatinib combined with Temozolomide on levels of sPD-1 and sPD-L1 in patients with drug-resistant recurrent glioblastoma

Published Print: 2024-01

Authors

Kuang, Ren Zhao http://orcid.org/0009-0003-4307-1722
Wang, Jun http://orcid.org/0009-0000-6312-1625
Wang, Yuan Chuan http://orcid.org/0009-0001-6447-4307
Tang, Xiao Ping http://orcid.org/0009-0001-2169-5337
Funding

Funding for this research was provided by:

Bureau of Science and Technology Nanchong City
License Information

Text and Data Mining valid from 2024-01-01

Text and Data Mining valid from 2024-01-01

Version of Record valid from 2024-04-26
More Information

This article is maintained by: Elsevier

Article Title: Effects of Apatinib combined with Temozolomide on levels of sPD-1 and sPD-L1 in patients with drug-resistant recurrent glioblastoma

Journal Title: Clinics

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.clinsp.2024.100376

Content Type: article

Copyright: © 2024 HCFMUSP. Published by Elsevier España, S.L.U.

Document is current